CYTOKINETICS REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS Primary Results and Two Additional Analyses from SEQUOIA-HCM to be Presented in a Late-Breaking Clinical Trial Session at the European Society of Cardiology Heart Failure 2024 Congress Initiated Enrollment in CEDAR-HCM, a Clinical Trial of Aficamten in a Pediatric Population with Obstructive HCM Announced Topline Data from the Phase 1 Study of CK-586; Phase 2 Clinical Trial to Begin in Q4 2024 SOUTH SAN FRANCISCO, Calif., May 8, 2024 - Cytokinetics, ...